aims to be an innovative drug discovery and development company - Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc 00:00:00
Michael Martino has extensive experience in the life sciences, spanning a 35-year career. He was previously acting-CEO and Director of HemaFlo Therapeutics, a start-up developing a novel therapy for Acute Kidney Injury, and serves on the board of Caravan Biologix, a start-up developing novel drugs, primarily for oncology.